On March 5, recipients of the 2022 LCRF and EGFR Resisters Research Grant on EGFR-Driven Lung Cancer provided an informative update on their research projects.

Ivy Elkins and Jill Feldman from EGFR Resisters hosted speakers Jonathan Ostrem, MD, PhD, University of California, San Francisco; Swarnali Acharyya, PhD, Columbia University Medical Center; and Luke Hoeppner, PhD, University of Minnesota, Twin Cities.

Watch the replay below.